Relationship of the dose of intravenous gammaglobulin to the prevention of infections in adults with common variable immunodeficiency

Inflammation

Volumn 20, Issue 4, 1996, Pages 353-359

  Pruzanski, Waldemar ^a   Sussman, Gordon ^a   Dorian, William ^a   Van, Tomas ^a   Ibanez, Dolores ^a   Redelmeier, Donald ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ADULT; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DYSPNEA; FEVER; FLUSHING; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LACRIMAL GLAND DISEASE; MORBIDITY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

EID: 0029736668     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01486738     Document Type: Article

References (21)

1. Consensus on IVIG. 1990. Editorial. Lancet. 2:470-472.
2. EIBL, M., and R. J. WEDGWOOD. 1989. Intravenous immunoglobulin: a review. Immunodef. Rev. 1(Suppl. 1): 1-42.
3. BERKMAN, S. A., M. LEE, and R. G. GALE. 1990. Clinical uses of intravenous immunoglobulin. Ann. Intern. Med. 112:278-292.
4. EIBL, M. M., and R. J. WEDGWOOD. 1993. Intravenous immunoglobulin: A review. In Immunodeficiencies. F. S. Rosen and M. Seligmann, editors. Academic Publishers, Harwood. pp. 659-688.
5. BERNATOWSKA, E., K. MADALINSKI, W. JANOWICZ, R. WEREMOWICZ, P. GUTKOWSKI, H. M. WOLF, and M. M. EIBL. 1987. Results of a prospective controlled two-dose crossover study with intravenous immunoglobulin and comparison (retrospective) with plasma treatment. Clin. Immunol. Immunopathol. 43:153-162.
6. STEELE, R. W., R. A. AUGUSTINE, A. S. TANNENBAUM, and D. J. MARMER. 1985. Intravenous immune globulin for hypogammaglobulinemia: A comparison of opsonizing capacity in recipient sera. Clin. Immunol. Immunopathol. 34:275-283.
7. PIROFSKY, B. 1984. Intravenous immune globulin therapy in hypogammaglobulinemia. A Review. Am. J. Med. 76:53-60.
8. CUNNINGHAM-RUNDLES, C. 1986. Treatment of AB deficiencies. Vox Sang. (Suppl. 2) 51:63-68.
9. MANKARIOUS, S., M. LEE, S. FISCHER, K. H. PYUN, H. D. OCHS, V. A. OXELIUS, and R. J. WEDGWOOD. 1988. The half-lives of IgG subclasses and specific antibodies in patients with primary immunodeficiency who are receiving intravenously administered immunoglobulin. J. Lab. Clin. Med. 112:634-640.
10. OCHS, H. D., S. H. FISHER, R. J. WEDGWOOD, D. W. WARA, M. J. COWAN, A. J. AMMANN, A. SAXON, M. D. BUDINGER, R. J. ALLRED, and R. H. ROUSELL. 1984. Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency disease. Am. J. Med. pp. 78-82.
11. DWYER, J. M. 1992. Manipulating the immune system with immune globulin. N. Engl. J. Med. 326:107-116.
12. GELFAND, E. W. 1992. Treatment of autoimmune diseases with intravenous gammaglobulin. Sem. Hemat. (Suppl. 2) 29:127-133.
13. KAVERI, S. V., G. DIETRICH, and M. D. KAZATCHKINE. 1992. Can intravenous immunoglobulin treatment regulate autoimmune responses? Semin. Hematol. (Suppl. 2) 29:64-71.
14. ACHIRON, A., R. MARGALIT, R. HERSHKOVIZ, D. MARKOVITS, T. RESHEF, E. MELAMED, I. R. COHEN, and O. LIDER. 1994. Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor a secretion. J. Clin. Invest. 93:600-605.
15. ABE, Y., A. HORIUCHI, M. MIYAKE, and S. KIMURA. 1994. Anti-cytokine nature of natural human immunoglobulin: One possible mechanism of the clinical effect of intravenous immunoglobulin therapy. Immuno. Rev. 139:5-19.
16. SUNDBLAD, A., M-A. R. MARCOS, E. MALANCHERE, A. CASTRO, M. HAURY, F. HUETZ, A. NOBREGA, A. FREITAS, and A. CUTINHO. 1994. Observations on the mode of action of normal immunoglobulin at high doses. Immunol Rev. 139:125-158.
17. BARANDUN, S., P. KISTLER, F. JEUNET, and H. ISLIKER. 1962. Intravenous administration of human gammaglobulin. Vox Sang. 7:157-174.
18. SORENSEN, R. U., and S. H. POLMAR. 1984. Efficacy and safety of high-dose intravenous immune globulin therapy for antibody deficiency syndrome. Am. J. Med. 76:83-90.
19. EIBL, M. M., L. CAIRNS, and F. S. ROSEN. 1984. Safety and efficacy of a monomeric, functionally intact intravenous IgG preparation in patients with primary immunodeficiency syndromes. Clin. Immunol. Immunopathol. 31:151-160.
20. World Health Organization Scientific Group Report. 1989. Primary Immunodeficiency Diseases. Immunodeficiency Rev. 1:173-205.
21. MONTANARO, A., and B. PIROFSKY. 1984. Prolonged interval high-dose intravenous immunoglobulin in patients with primary immunodeficiency states. Am. J. Med. 76:67-72.